Results 131 to 140 of about 24,285 (193)

Screening for Fabry Disease in Patients With Juvenile Systemic Lupus Erythematosus. [PDF]

Arch Rheumatol, 2020
Kiykim E, Şahİn S, ZubarioĞlu T, Barut K, Adrovic A, Cansever MŞ, AktuĞlu Zeybek AÇ, KasapÇopur Ö.   +7 more
europepmc   +1 more source

Biologic therapy for autoimmune diseases: an update [PDF]

, 2013

core   +1 more source

Identifying distinct phenotypes of patients with juvenile systemic lupus erythematosus: results from a cluster analysis by the Egyptian college of rheumatology (ECR) study group. [PDF]

BMC Pediatr
Hammam N, Gheita TA, Bakhiet A, Mahmoud MB, Owaidy RE, Nabi HA, Elsaman AM, Khalifa I, ElBaky AMNEA, Ismail F, Hassan E, El Shereef RR, El-Gazzar II, Moshrif A, Khalil NM, Amer MA, Fathy HM, Salam NA, Elazeem MIA, Hammam O, Fathi HM, Tharwat S.   +21 more
europepmc   +1 more source

Coexistence of Juvenile Systemic Lupus Erythematosus and Juvenile Spondyloarthropathy: A Case Report and Review of the Literature. [PDF]

Arch Rheumatol, 2020
Tanatar A, Topal U, GÜl KaradaĞ Ş, SÖnmez HE, Aktay Ayaz N.   +4 more
europepmc   +1 more source

The Comparison of Nailfold Capillaroscopy between Juvenile Systemic Lupus Erythematosus and Healthy Controls: Correlation with Laboratory and Clinical Parameters. [PDF]

Int J Vasc Med, 2020
Raeeskarami SR, Namazi N, Assari R, Najafizadeh SR, Hassannejad Z, Ziaee V.   +5 more
europepmc   +1 more source

24. Juvenile Systemic Lupus Erythematosus and Juvenile Myasthenia Gravis [PDF]

Rheumatology, 2014
openaire   +1 more source

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study [PDF]

, 2015

core   +1 more source

Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. [PDF]

Pediatr Rheumatol Online J, 2020
Dave M, Rankin J, Pearce M, Foster HE.
europepmc   +1 more source